Dec 272017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Eloxx Pharmaceuticals, Inc. (OTCQB:SVOND), a clinical-stage biopharmaceutical company developing novel small molecule medicines to treat rare and ultra-rare genetic diseases caused by nonsense mutations today announced that Robert (“Bob”) Ward has been appointed Chairman of the Board of Directors of Eloxx and Chief Executive Officer effective immediately.… => Read Full post

Eloxx Pharmaceuticals appoints Bob Ward to its Board of Directors as CEO and Chairman

From:: Eloxx Pharmaceuticals appoints Bob Ward to its Board of Directors as CEO and Chairman

Sorry, the comment form is closed at this time.

%d bloggers like this: